As proof of concept, we genetically modified CD19+ B-leukemia/lymphoma cell lines with the bicistronic vector encoding for iC9.CAR.CD19, in order to reproduce a CAR+ CD19-masked leukemic clonotype (Figure 1A). This evidence concerns the gene CD19 and lymphoma.